In China, the release of Sinovac’s Phase 3 trial results for its coronavirus vaccine puts it one step closer towards mass use, globally. But Coronavac has already been widely administered in China, along with drugs developed by the other front-running Chinese vaccine manufacturer, Sinopharm. Patrick Fok spoke to a person who’s had the jab.
China’s three Covid-19 vaccine candidates continue to develop
